Natco Pharma net profit decline 9% in September quarter
Sales of active pharmaceutical ingredients, the key raw materials that go into the manufacture of drugs, declined 30% to `52 crore13-11-2015
Natco Pharma net profit decline 9% in September quarter
Sales of active pharmaceutical ingredients, the key raw materials that go into the manufacture of drugs, declined 30% to `52 croreFixes Record Date for Stock Split
Natco Pharma Ltd has informed BSE that the Company has fixed Record Date as November 28, 2015 for the purpose of sub-division of 1 (One) Equity Share of Face Value of Rs. 10/- each into 5 (Five) Equity shares of Rs. 2/- each.Results Press Release
Natco Pharma Ltd has submitted to BSE a copy of Results Press Release for the period ended September 30, 2015.Announces Q2 results
Natco Pharma Ltd has announced the following results for the quarter ended September 30, 2015 :The Un-Audited Standalone results for the Quarter ended September 30, 2015The Company has posted a net profit of Rs. 346.00 million for the quarter ended September 30, 2015 as compared to Rs. 348.00 million for the quarter ended September 30, 2014. Total Income has increased from Rs. 1942.80 million for the quarter ended September 30, 2014...Q2 results on Nov 13, 2015
Natco Pharma Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on November 13, 2015, inter alia, to consider the following:1. The unaudited financial Results for the quarter and half year ended September 30, 2015 (Q2) and related matters.2. To fix record date for Sub-Division of 1 (One) Equity Share of face value of Rs.10/- each into 5 (Five) Equity Shares of Rs. 2/- Each....Newspaper Advetisement for Notice of Postal Ballot
Natco Pharma Ltd has submitted to BSE a copy of Notice of Postal Ballot published in Newspapers.Natco launches Hepatitis C drug in Nepal
Hyderabad-based Natco Pharma today said it has launched the first licensed generic version of Hepatitis C medicine under its brand name Hepcinat LP in Nepal.NATCO launches HEPCINAT LP in Nepal
Natco Pharma Ltd has submitted to BSE a copy of Press Release dated October 28, 2015 titled "NATCO launches HEPCINAT LP in Nepal".Natco Pharma betting big on discovery research
Company to leverage its strengths in oncology, develop its own moleculeNatco Pharma bags award
Natco Pharma has been presented with the Golden Peacock innovation management award for 2015. The Hyderabad-based companys Director & President (R&D and Tech), AKS Bhujang...